Aspira Women's Health Reports Material Agreements & Officer Changes

Ticker: AWHL · Form: 8-K · Filed: 2025-04-08T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, equity-sale, officer-changes

Related Tickers: AWH

TL;DR

Aspira Women's Health (AWH) filed an 8-K detailing new deals, stock sales, and exec changes on April 2nd.

AI Summary

Aspira Women's Health Inc. filed an 8-K on April 8, 2025, reporting on several key events that occurred on April 2, 2025. These include entering into a material definitive agreement, unregistered sales of equity securities, and changes related to director and officer positions, including compensatory arrangements. The filing also covers other events and financial statements.

Why It Matters

This 8-K filing indicates significant corporate actions, including potential new agreements and changes in leadership or compensation, which could impact the company's strategic direction and financial performance.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity securities, which can carry inherent risks related to deal terms, dilution, and regulatory compliance.

Key Players & Entities

FAQ

What was the nature of the material definitive agreement entered into by Aspira Women's Health?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.

What type of equity securities were sold in the unregistered sale?

The filing mentions unregistered sales of equity securities, but the specific type and amount of securities are not detailed in the provided summary.

Were there any departures or elections of directors or officers on April 2, 2025?

Yes, the filing reports on the departure of directors or certain officers, election of directors, and appointment of certain officers, as well as compensatory arrangements.

What is the SIC code for Aspira Women's Health Inc.?

The Standard Industrial Classification (SIC) code for Aspira Women's Health Inc. is 2835, which pertains to IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.

What were the former names of Aspira Women's Health Inc.?

Aspira Women's Health Inc. was formerly known as VERMILLION, INC. (name change effective August 24, 2007), CIPHERGEN BIOSYSTEMS INC (name change effective March 16, 2000), and ABIOTIC SYSTEMS (name change effective April 7, 1995).

From the Filing

0001641172-25-003135.txt : 20250408 0001641172-25-003135.hdr.sgml : 20250408 20250408083036 ACCESSION NUMBER: 0001641172-25-003135 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250402 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250408 DATE AS OF CHANGE: 20250408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 25820371 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 form8-k.htm false 0000926617 0000926617 2025-04-02 2025-04-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 2, 2025       Aspira Women’s Health Inc. (Exact name of Registrant as Specified in Its Charter)       Delaware   001-34810   33-0595156 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   12117 Bee Caves Road Building III Suite 100     Austin , Texas   78738 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: 512 519-0400     (Former Name or Former Address, if Changed Since Last Report)       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.001 per share   AWH   The Nasdaq Stock Market   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).   Emerging growth company ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pu

View on Read The Filing